Key Conclusion The outlook for Portola’s stock price in 2019 and 2020 will almost certainly driven by the sales progress of Andexxa. At this early stage in the launch, there is considerable uncertainty and guesswork involved in projecting sales. My preliminary estimates are that sales increase from $24 million in 2019 to $120 million in […]
Welcome to SmithonStocks (SOS), home to in-depth financial analysis and research reports with a focus on emerging biotechnology companies.
You now must be a subscriber in order to gain full access to new and featured reports. Please click the "Subscribe" button to register for a SoS subscription. If you are already have a SoS subscription account please log in now.
As always, all blog posts and old reports do not require a subscription to read.
Thank you for visiting SmithonStocks.com.